ArticleACS biomaterials science & engineering2026
Quantifying the Dual Effect of Antitumor and Pro-Tumor Human Neutrophils on Natural Killer Cell Behaviors in a Microphysiological System.
Article in ACS biomaterials science & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neutrophils, the most abundant immune cells in humans, can promote the progression of many solid tumors. Neutrophils in solid tumor tissues can contribute to immunosuppression and resistance to immunotherapy partially by inhibiting the antitumor activity of natural killer (NK) cells, a group of innate immune cells known as the first line of defense against cancer. Studies in mice show that neutrophils are functionally plastic and can be polarized by molecular cues to show either an antitumor "N1" or a pro-tumor "N2" phenotype. However, the crosstalk between neutrophils and NK cells in human cancer is not well characterized, especially as to how different subtypes of neutrophils could influence NK cell behaviors differently. In this study, we engineered a human cell-based microphysiological system to quantify the distinct effects of antitumor N1-like and pro-tumor N2-like neutrophil subtypes on NK cell behaviors including migration and tumor cytotoxicity. We found that NK cells showed preferential migration toward N1-like neutrophils over N2-like neutrophils, although they showed lower motility in terms of speed, displacement, and directionality after migration toward N1-like neutrophils in comparison to N2-like neutrophils. Moreover, N1-like neutrophils restored the NK cell cytotoxicity against pancreatic tumor spheroids, while N2-like neutrophils suppressed it, although both neutrophil subtypes inhibited NK cell infiltration into tumor spheroids. Our study reveals the dual role of human neutrophils in modulating NK cell behaviors and sheds new light on the nuanced crosstalk between different immune cell types, suggesting the reprogramming of neutrophils to enhance the antitumor functions of NK cells as a potential immunotherapy strategy for cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.